Clinical Trial Update: Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists [NA]

View source ↗

Summary

An update on an ongoing trial evaluating a drinkable nutraceutical for hair loss in patients using GLP-1/GIP receptor agonists (Telogen Effluvium), with recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telogen Effluvium

Drugs mentioned

• Nutraceutical drink for hair loss

Snippet

Sponsor: Olistic Research Labs S.L. | Conditions: Telogen Effluvium | NA | Status: RECRUITING